Diethylamine

Diethylamine

SCHEMBL358240

CCNCC.CCOC(=O)CCCCC(=O)OCC

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Diethylamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.59
GAA P10253 2/20 0.54
MGAM O43451 1/20 0.54
SI P14410 1/20 0.54
MGAM2 Q2M2H8 1/20 0.54
ALDH1A1 P00352 4/20 0.49
KMT2A Q03164 2/20 0.49
ALOX15 P16050 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
CYP3A4 P08684 1/20 0.49
TSHR P16473 1/20 0.49
HSD17B10 Q99714 1/20 0.49
DGKA P23743 1/20 0.48
NR1I2 O75469 1/20 0.47
PGR P06401 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
PTGS2 P35354 1/20 0.47
PDE4D Q08499 1/20 0.47
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethylamine SCHEMBL5793553 0.92 DGKA (0.62) CYP1A2GAAALDH1A1KMT2AALOX15
SCHEMBL8570508 0.88 CYP1A2 (0.73) CYP1A2GAAMGAMSIMGAM2
SCHEMBL50610 0.88 CYP1A2 (0.73) CYP1A2GAAMGAMSIMGAM2
SCHEMBL130596 0.88 CYP1A2 (0.52) CYP1A2GAAMGAMSIMGAM2
SCHEMBL132536 0.88 CYP1A2 (0.52) CYP1A2GAAMGAMSIMGAM2
SCHEMBL8367259 0.87 CYP1A2 (0.55) CYP1A2GAAMGAMSIMGAM2
Dimethylamine SCHEMBL16909987 0.86 CYP1A2 (0.64) CYP1A2GAAMGAMSIMGAM2
SCHEMBL6055406 0.85 CYP1A2 (0.70) CYP1A2GAAMGAMSIMGAM2
SCHEMBL495925 0.85 CYP1A2 (0.70) CYP1A2GAAMGAMSIMGAM2
SCHEMBL33870 0.85 CYP1A2 (0.70) CYP1A2GAAMGAMSIMGAM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014100921-A1 FOAM GASKET AND BONDING TAPE BASED ON POLYURETHANE DISPERSIONS SAINT-GOBAIN PERFORMANCE PLASTICS CORPORATION (US) 2014-07-03 WO claimed
US-20260005355-A1 CURABLE POTTING MATERIAL FOR AUTOMOTIVE BATTERY PACKS SIKA TECHNOLOGY AG (CH) 2026-01-01 US disclosed
EP-4655329-A1 CURABLE POTTING MATERIAL FOR AUTOMOTIVE BATTERY PACKS Sika Technology AG (CH) 2025-12-03 EP disclosed
EP-4652037-A1 LAMINATED PARTS CONTAINING A HARD POLYURETHANE OUTER LAYER AND METHODS FOR THEIR PRODUCTION Covestro LLC (US) 2025-11-26 EP disclosed
WO-2025233647-A1 BATTERY BOX COMPRISING A FOAMED POLISOCYANURATE MATERIAL SIKA TECHNOLOGY AG (CH) 2025-11-13 WO disclosed
EP-4638156-A1 HYBRID COIL SPRING ISOLATOR BASF SE (DE) 2025-10-29 EP disclosed
US-12448552-B2 Adhesive bond between a thermoplastic material and an elastomer composition SIKA TECHNOLOGY AG (CH) 2025-10-21 US disclosed
US-20250313681-A1 SUBSTRATES WITH RESIN COMPOSITION ADHERED THERETO AND METHODS FOR IMPROVING ADHESION TO A SUBSTRATE MOMENTIVE PERFORMANCE MAT INC (US) 2025-10-09 US disclosed
WO-2025202053-A1 CURABLE POLYURETHANE COMPOSITION WITH ISOCYANURATE SILANES SIKA TECHNOLOGY AG (CH) 2025-10-02 WO disclosed
EP-4624503-A1 CURABLE POLYURETHANE COMPOSITION WITH ISOCYANURATE SILANES Sika Technology AG (CH) 2025-10-01 EP disclosed
US-4182829-A Impression materials for dentistry BAYER AKTIENGESELLSCHAFT (DE) 1980-01-08 US disclosed
US-4156059-A Inorganic-organic polymers and processes for their manufacture CHEMIE-ANLAGENBAU BISCHOFSHEIM GMBH (DE) 1979-05-22 US disclosed
US-4147680-A Production of polyurethane resins using as active hydrogen material a stable dispersion of ionic polyisocyanate-polyaddition products in hydroxyl containing compounds as a dispersing agent BAYER AKTIENGESELLSCHAFT (DE) 1979-04-03 US disclosed
US-4128532-A Polyetheresters which contain hydroxyl groups and the use thereof in the production of flame resistant synthetic resins BAYER AKTIENGESELLSCHAFT (DE) 1978-12-05 US disclosed
US-4123599-A PHENOLIC RESINS REACTED WITH ORGANIC DIISOCYANATES AND/OR POLYISOCYANTES IN THE PRESENCE OF METAL POWDERS AND/OR METAL OXIDE POWDERS CHEMIE-ANLAGENBAU BISCHOFSHEIM GMBH (DE) 1978-10-31 US disclosed
US-4120923-A Process for manufacturing foamed materials involving contacting a thin unbroken film of liquid resin with a gaseous blowing agent under pressure BAYER AKTIENGESELLSCHAFT (DE) 1978-10-17 US disclosed
US-4093569-A Polyurethane resins produced from active hydrogen containing material which is a dispersion of polyisocyanate-polyaddition products in hydroxyl containing compounds as dispersing agents BAYER AKTIENGESELLSCHAFT (DT) 1978-06-06 US disclosed
US-4024090-A Process for molding polyurethane foams BAYER AKTIENGESELLSCHAFT (DT) 1977-05-17 US disclosed
US-4013625-A Process for the linearization of polyurethanes with lactams and lactam addition compounds BAYER AKTIENGESELLSCHAFT (DT) 1977-03-22 US disclosed
US-3993606-A Process for the production of polyurethane foams BAYER AKTIENGESELLSCHAFT (DT) 1976-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260005355-A1 CURABLE POTTING MATERIAL FOR AUTOMOTIVE BATTERY PACKS ACIN1, TCP1, TES CYP1A2 2197/4885GAA 4347/4885MGAM 3298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.